Home › Zacks Investment Research Upgrades Medifast Inc (MED) to Buy
 

Keywords :   


Zacks Investment Research Upgrades Medifast Inc (MED) to Buy

2016-04-12 22:33:55| Biotech - Topix.net

The firm currently has $33.00 target price on the stock. According to Zacks, "Medifast Inc has one operating subsidiary, Jason Pharmaceuticals, Inc, its manufacturing arm.

Tags: buy research med investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
More »